tradingkey.logo
tradingkey.logo
Search

Mangoceuticals Inc

MGRX
Add to Watchlist
0.440USD
+0.047+11.93%
Close 05/15, 16:00ETQuotes delayed by 15 min
7.47MMarket Cap
LossP/E TTM

Mangoceuticals Inc

0.440
+0.047+11.93%

More Details of Mangoceuticals Inc Company

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Mangoceuticals Inc Info

Ticker SymbolMGRX
Company nameMangoceuticals Inc
IPO dateMar 21, 2023
CEOCohen (Jacob D)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMar 21
Address15110 Dallas Pkwy, Suite 600
CityDALLAS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75248
Phone18336264679
Websitehttps://www.mangorx.com/
Ticker SymbolMGRX
IPO dateMar 21, 2023
CEOCohen (Jacob D)

Company Executives of Mangoceuticals Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
9.05%
Cohen (Jacob D.)
7.75%
Ikarian Capital LLC
0.81%
Myers (Kenny)
0.81%
D'Alessio (Lorraine Pamela)
0.81%
Other
80.77%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
9.05%
Cohen (Jacob D.)
7.75%
Ikarian Capital LLC
0.81%
Myers (Kenny)
0.81%
D'Alessio (Lorraine Pamela)
0.81%
Other
80.77%
Shareholder Types
Shareholders
Proportion
Individual Investor
10.16%
Hedge Fund
9.87%
Investment Advisor
1.43%
Investment Advisor/Hedge Fund
1.09%
Research Firm
0.48%
Other
76.98%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
37
2.67M
15.75%
+2.15M
2025Q4
30
728.63K
4.73%
+350.56K
2025Q3
27
301.64K
2.21%
-28.95K
2025Q2
38
3.44M
29.63%
+1.40M
2025Q1
35
1.92M
37.79%
+1.11M
2024Q4
34
1.29M
45.58%
-18.06K
2024Q3
32
811.21K
40.72%
-490.52K
2024Q2
27
759.36K
45.89%
-544.02K
2024Q1
26
674.02K
59.33%
-527.17K
2023Q4
22
660.62K
58.15%
-532.64K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
1.54M
9.98%
+1.54M
--
Dec 31, 2025
Cohen (Jacob D.)
1.30M
8.48%
-500.00K
-27.70%
Jan 05, 2026
Ikarian Capital LLC
138.15K
0.9%
+138.15K
--
Dec 31, 2025
Myers (Kenny)
136.67K
0.89%
--
--
Jan 05, 2026
D'Alessio (Lorraine Pamela)
136.67K
0.89%
--
--
Jan 05, 2026
Johnston (Eugene M)
120.00K
0.78%
-1.00
-0.00%
Jan 05, 2026
Geode Capital Management, L.L.C.
108.32K
0.7%
+20.35K
+23.13%
Dec 31, 2025
Jane Street Capital, L.L.C.
47.50K
0.31%
+47.50K
--
Dec 31, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Date
Ex-dividend Date
Type
Ratio
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
KeyAI